Strongbridge Biopharma PLC | Key People and Executives
Matthew Pauls
President, Chief Executive Officer & Director
Hilde Hermansen Steineger
Independent Director
Marten Steen
Independent Director
Jeffrey W. Sherman
Director
Garheng Kong
Independent Director
Richard S. Kollender
Independent Director
Matthew Pauls
President, Chief Executive Officer & Director
A. Brian Davis
CFO & Principal Accounting Officer
Steven L. Schoenfeld
Vice President-Clinical Research & Development
Fredric Cohen
Chief Medical Officer
Stephen J. Moloney
Vice President-Global Medical Affairs
Brian Conner
Vice President & Head-Compliance
Peter J. Valentinsson
Senior Vice President-Global Technical Operations
Robert Lutz
Chief Business Officer
James R. Englund
Vice President & Controller
Susan Thornton
Vice President-Regulatory Affairs
Dave Bonnell
Senior Vice President-Sales & Marketing
Stephen J. Long
Secretary & Chief Legal Officer
Hilde Hermansen Steineger
Independent Director
Marten Steen
Independent Director
Jeffrey W. Sherman
Director
Garheng Kong
Independent Director
Richard S. Kollender
Independent Director
| Address |
900 Northbrook Drive
Lower Southampton Pennsylvania 19053
United States
|
|
Employees
|
- |
| Website |
http://www.strongbridgebio.com |
| Updated |
07/08/2019 |
| Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA. |
